These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Neuroendocrine regulation of growth hormone secretion in sheep. II. Effect of somatostatin on growth hormone and glucose levels. Spencer GS; Bass JJ; Hodgkinson SC; Dobbie P Domest Anim Endocrinol; 1991 Jul; 8(3):375-81. PubMed ID: 1684144 [TBL] [Abstract][Full Text] [Related]
5. Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans. Hildebrand P; Ensinck JW; Ketterer S; Delco F; Mossi S; Bangerter U; Beglinger C J Clin Endocrinol Metab; 1991 May; 72(5):1123-9. PubMed ID: 2022712 [TBL] [Abstract][Full Text] [Related]
6. Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro-entero-pancreatic hormones in man. Feedback control of cholecystokinin and gastrin secretion. Schmidt WE; Creutzfeldt W; Höcker M; Nustede R; Choudhury AR; Schleser A; Rovati LC; Fölsch UR Eur J Clin Invest; 1991 Oct; 21(5):501-11. PubMed ID: 1752290 [TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine regulation of growth hormone secretion in sheep. VII. Effects of GABA. Spencer GS; Berry CJ; Bass JJ Regul Pept; 1994 Aug; 52(3):181-6. PubMed ID: 7800850 [TBL] [Abstract][Full Text] [Related]
8. Elevation of feed intake in parasite-infected lambs by central administration of a cholecystokinin receptor antagonist. Dynes RA; Poppi DP; Barrell GK; Sykes AR Br J Nutr; 1998 Jan; 79(1):47-54. PubMed ID: 9505802 [TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine regulation of growth hormone secretion in sheep. VI. Intracerebroventricular administration of galanin. Spencer GS; Berry CJ; Bass JJ Neuroreport; 1994 Jan; 5(4):522-4. PubMed ID: 7516200 [TBL] [Abstract][Full Text] [Related]
10. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori. Konturek JW J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of intraduodenal infusion of loxiglumide on pancreatic exocrine secretion. Tanikawa M; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Kodaira T; Hamaoka T Arzneimittelforschung; 1993 Jan; 43(1):35-9. PubMed ID: 8447844 [TBL] [Abstract][Full Text] [Related]
12. Hypothalamic somatostatin mediates the suppression of growth hormone secretion by centrally administered thyrotropin-releasing hormone in conscious rats. Katakami H; Arimura A; Frohman LA Endocrinology; 1985 Sep; 117(3):1139-44. PubMed ID: 2862016 [TBL] [Abstract][Full Text] [Related]
14. Role of endogenously released cholecystokinin in determining postprandial insulin levels in man: effects of loxiglumide, a specific cholecystokinin receptor antagonist. Baum F; Nauck MA; Ebert R; Cantor P; Hoffmann G; Choudhury AR; Schmidt WE; Creutzfeldt W Digestion; 1992; 53(3-4):189-99. PubMed ID: 1291406 [TBL] [Abstract][Full Text] [Related]
15. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man. Gabryelewicz A; Kulesza E; Konturek SJ Scand J Gastroenterol; 1990 Jul; 25(7):731-8. PubMed ID: 2396088 [TBL] [Abstract][Full Text] [Related]
16. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide. Fried M; Erlacher U; Schwizer W; Löchner C; Koerfer J; Beglinger C; Jansen JB; Lamers CB; Harder F; Bischof-Delaloye A Gastroenterology; 1991 Aug; 101(2):503-11. PubMed ID: 2065926 [TBL] [Abstract][Full Text] [Related]
17. The effect of cholecystokinin peptides on ovine duodeno-jejunal slow waves with and without pretreatment with proglumide. Romański KW J S Afr Vet Assoc; 2007 Dec; 78(4):209-14. PubMed ID: 18507220 [TBL] [Abstract][Full Text] [Related]
18. The effects of the cholecystokinin antagonist, proglumide, on gonadotropin release in the rat. Vijayan E; McCann SM Brain Res Bull; 1986 Apr; 16(4):533-6. PubMed ID: 3087585 [TBL] [Abstract][Full Text] [Related]
19. Effects of cholecystokinin receptor blockade on circulating concentrations of glucose, insulin, C-peptide, and pancreatic polypeptide after various meals in healthy human volunteers. Niederau C; Schwarzendrube J; Lüthen R; Niederau M; Strohmeyer G; Rovati L Pancreas; 1992; 7(1):1-10. PubMed ID: 1557335 [TBL] [Abstract][Full Text] [Related]
20. Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man. Schmidt WE; Creutzfeldt W; Höcker M; Choudhury AR; Nustede R; Schleser A; Nitsche R; Rovati LC; Schafmayer A; Fölsch UR Digestion; 1990; 46 Suppl 2():232-9. PubMed ID: 2262057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]